Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity
Agnes Mwakingwe-Omari, Sara A. Healy, Jacquelyn Lane, et al.
Nature (2021) Vol. 595, Iss. 7866, pp. 289-294
Closed Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Tafenoquine-Atovaquone Combination Achieves Radical Cure and Confers Sterile Immunity in Experimental Models of Human Babesiosis
Pratap Vydyam, Anasuya Pal, Isaline Renard, et al.
The Journal of Infectious Diseases (2024) Vol. 229, Iss. 1, pp. 161-172
Closed Access | Times Cited: 19
Malaria vaccines: a new era of prevention and control
Patrick E. Duffy, J. Patrick Gorres, Sara A. Healy, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 12, pp. 756-772
Closed Access | Times Cited: 19
Single immunization with genetically attenuated Pf∆mei2 (GA2) parasites by mosquito bite in controlled human malaria infection: a placebo-controlled randomized trial
Geert V.T. Roozen, Roos van Schuijlenburg, A Hensen, et al.
Nature Medicine (2025)
Open Access | Times Cited: 3
Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial
Mahamadou S. Sissoko, Sara A. Healy, Abdoulaye Katilé, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 3, pp. 377-389
Open Access | Times Cited: 67
Malaria in 2022: Increasing challenges, cautious optimism
Prasanna Jagannathan, Abel Kakuru
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 64
Malaria Vaccines: Progress to Date
Danielle I. Stanisic, Michael F. Good
BioDrugs (2023) Vol. 37, Iss. 6, pp. 737-756
Open Access | Times Cited: 34
Sporozoite immunization: innovative translational science to support the fight against malaria
Thomas L. Richie, L. W. Preston Church, Tooba Murshedkar, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 964-1007
Open Access | Times Cited: 27
A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion
Debashree Goswami, Hardik Patel, William Betz, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 4, pp. 723-754
Open Access | Times Cited: 15
Vaccines and monoclonal antibodies: new tools for malaria control
Kazutoyo Miura, Yevel Flores-García, Carole A. Long, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 11
Safety and efficacy of PfSPZ Vaccine against malaria in healthy adults and women anticipating pregnancy in Mali: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
Halimatou Diawara, Sara A. Healy, Agnes Mwakingwe-Omari, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 12, pp. 1366-1382
Closed Access | Times Cited: 11
Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria Parasite
Olivia A.C. Lamers, Blandine Franke‐Fayard, Jan Pieter R. Koopman, et al.
New England Journal of Medicine (2024) Vol. 391, Iss. 20, pp. 1913-1923
Closed Access | Times Cited: 10
Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine
Zachary MacMillen, Kiara Hatzakis, Adrian Simpson, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
A genetically engineered Plasmodium falciparum parasite vaccine provides protection from controlled human malaria infection
Sean C. Murphy, Ashley M. Vaughan, James G. Kublin, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 659
Open Access | Times Cited: 36
Malaria in 2022: Challenges and Progress
Philip J. Rosenthal
American Journal of Tropical Medicine and Hygiene (2022) Vol. 106, Iss. 6, pp. 1565-1567
Open Access | Times Cited: 35
A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection
Benjamin Mordmüller, Zita Sulyok, Mihály Sulyok, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 35
Current approaches to malaria vaccines
Patrick E. Duffy
Current Opinion in Microbiology (2022) Vol. 70, pp. 102227-102227
Open Access | Times Cited: 31
Malaria therapeutics: are we close enough?
Himani Tripathi, Preshita Bhalerao, Sujeet Singh, et al.
Parasites & Vectors (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 17
Strategic and scientific contributions of human challenge trials for vaccine development: facts versus fantasy
Yara‐Natalie Abo, Euzebiusz Jamrozik, James McCarthy, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 12, pp. e533-e546
Open Access | Times Cited: 17
Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5
Lawrence Wang, Andrew J. R. Cooper, Brendan Farrell, et al.
Cell (2024) Vol. 187, Iss. 18, pp. 4981-4995.e14
Open Access | Times Cited: 6
Five decades of clinical assessment of whole-sporozoite malaria vaccines
Helena Nunes‐Cabaço, Diana Moita, Miguel Prudêncio
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Creation and preclinical evaluation of genetically attenuated malaria parasites arresting growth late in the liver
Blandine Franke‐Fayard, Catherin Marin-Mogollon, Fiona J. A. Geurten, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 22
Genome-wide gene expression profiles throughout human malaria parasite liver stage development in humanized mice
Gigliola Zanghì, Hardik Patel, Jenny L. Smith, et al.
Nature Microbiology (2025) Vol. 10, Iss. 2, pp. 569-584
Open Access
Protective targets of PfSPZ vaccines identified from whole-genome sieve analysis of isolates from malaria vaccine efficacy trials in West Africa
Ankit Dwivedi, Ryan J. Scalsky, David G. Harris, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Repeated Plasmodium falciparum infection in humans drives the clonal expansion of an adaptive γδ T cell repertoire
Anouk von Borstel, Priyanka Chevour, Daniel Arsovski, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 622
Open Access | Times Cited: 30
Multi-Dose Priming Regimens of PfSPZ Vaccine: Safety and Efficacy against Controlled Human Malaria Infection in Equatoguinean Adults
Said Jongo, L. W. Preston Church, Vicente Urbano Nsue Ndong Nchama, et al.
American Journal of Tropical Medicine and Hygiene (2022) Vol. 106, Iss. 4, pp. 1215-1226
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top